137945-57-4

Basic information

• Product Name: (6AR,10AR)-1-(TERT-BUTYL-DIMETHYL-SILANYLOXY)-3-(1,1-DIMETHYL-HEPTYL)-6,6-DIMETHYL-6A,7,10,10A-TETRAHYDRO-6H-BENZO[C]CHROMENE-9-CARBALDEHYDE
• Synonyms: (6AR,10AR)-1-(TERT-BUTYL-DIMETHYL-SILANYLOXY)-3-(1,1-DIMETHYL-HEPTYL)-6,6-DIMETHYL-6A,7,10,10A-TETRAHYDRO-6H-BENZO[C]CHROMENE-9-CARBALDEHYDE
• CAS NO: 137945-57-4
• Molecular Formula: C31H50O3Si
• Molecular Weight: 498.8124
• Mol File: 137945-57-4.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 518.9±50.0 °C(Predicted)
• Appearance: /
• Density: 0.983±0.06 g/cm3(Predicted)
• CAS DataBase Reference: (6AR,10AR)-1-(TERT-BUTYL-DIMETHYL-SILANYLOXY)-3-(1,1-DIMETHYL-HEPTYL)-6,6-DIMETHYL-6A,7,10,10A-TETRAHYDRO-6H-BENZO[C]CHROMENE-9-CARBALDEHYDE(CAS DataBase Reference)
• NIST Chemistry Reference: (6AR,10AR)-1-(TERT-BUTYL-DIMETHYL-SILANYLOXY)-3-(1,1-DIMETHYL-HEPTYL)-6,6-DIMETHYL-6A,7,10,10A-TETRAHYDRO-6H-BENZO[C]CHROMENE-9-CARBALDEHYDE(137945-57-4)
• EPA Substance Registry System: (6AR,10AR)-1-(TERT-BUTYL-DIMETHYL-SILANYLOXY)-3-(1,1-DIMETHYL-HEPTYL)-6,6-DIMETHYL-6A,7,10,10A-TETRAHYDRO-6H-BENZO[C]CHROMENE-9-CARBALDEHYDE(137945-57-4)

Safety Data

• Hazardous Substances Data: 137945-57-4(Hazardous Substances Data)

Usage

General Description

The chemical "(6aR,10aR)-1-(tert-Butyl-dimethyl-silanyloxy)-3-(1,1-dimethyl-heptyl)-6,6-dimethyl-6a,7,10,10a-tetrahydro-6H-benzo[c]chromene-9-carbaldehyde" is a complex organic compound with a long and unique molecular structure. It contains a benzochromene ring, a carbaldehyde group, a tert-butyl-dimethyl-silanyloxy group, and a 1,1-dimethyl-heptyl group. (6aR,10aR)-1-(tert-Butyl-dimethyl-silanyloxy)-3-(1,1-dimethyl-heptyl)-6,6-dimethyl-6a,7,10,10a-tetrahydro-6H-benzo[c]chromene-9-carbaldehyde may have potential uses in the pharmaceutical or chemical industries, as its structure suggests it may have biological activity or be a precursor for the synthesis of other compounds. However, further research and testing would be needed to fully understand its properties and potential applications.

Upstream product

• 137945-54-1 2,2-Dimethyl-propionic acid (6aR,10aR)-1-(tert-butyl-dimethyl-silanyloxy)-3-(1,1-dimethyl-heptyl)-6,6-dimethyl-6a,7,10,10a-tetrahydro-6H-benzo[c]chromen-9-ylmethyl ester 
• 18162-48-6 tert-butyldimethylsilyl chloride 
• 113418-02-3 2,2-Dimethyl-propionic acid (6aR,10aR)-3-(1,1-dimethyl-heptyl)-1-hydroxy-6,6-dimethyl-6a,7,10,10a-tetrahydro-6H-benzo[c]chromen-9-ylmethyl ester 
• 137945-53-0 [(6aR,10aR)-1-(tert-Butyl-dimethyl-silanyloxy)-3-(1,1-dimethyl-heptyl)-6,6-dimethyl-6a,7,10,10a-tetrahydro-6H-benzo[c]chromen-9-yl]-methanol 

Downstream Products

• 137945-48-3 ajulemic acid 
• 137945-49-4 (6aR,10aR)-1-((tert-butyldimethylsilyl)oxy)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydro-6H-benzo[c]chromene-9-carboxylic acid 

Relevant articles and documents

ANTI-EMETIC USES OF (3R, 4R)-DELTA8-TETRAHYDROCANNABINOL-11-OIC ACIDS

The present invention relates to non-psychoactive derivatives of tetrahydrocannabinol, (3R,4R)-Δ8-THC-11-oic acids, for treating or preventing nausea and relieving symptoms thereof.

Synthetic Nonpsychotropic Cannabinoids with Potent Antiinflammatory, Analgesic, and Leukocyte Antiadhesion Activities

Two strategies for the design of therapeutically useful cannabinoids have been combined to produce compounds with greatly increased antiinflammatory activity and with a low potential for adverse side effects.Enantiomeric cannabinoids with a carboxylic acid group at position 7 and with an elongated and branched alkyl sidechain at position 5' have been synthesized and tested for antiinflammatory activity.They were effective when given orally at doses of 10 μg/kg in reducing paw edema in mice that had been induced by either arachidonic acid or platelet activating factor.Leukocyte adhesion to culture dishes was also reduced in peritoneal cells from mice in which the cannabinoids were orally administered in the same dose range as for the paw edema tests.Antinociception could be observed in the mouse hot plate assay; however, little stereochemical preference was seen in contrast to the above tests where the 3R,4R compounds are more active than the 3S,4S enantiomers.Finally, in agreement with earlier reports on the naturally occurring pentyl side chain acids, the synthetic acids showed little activity in producing catalepsy in the mouse, suggesting that they would be nonpsychotropic in humans.